Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 778 across all filing types
Latest filing 2015-04-15 Report Publication Anno…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
MAUNA KEA TECHNOLOGIES MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2014
Report Publication Announcement Classification · 99% confidence The document is titled "MAUNA KEA TECHNOLOGIES MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2014" (Mauna Kea Technologies makes available the 2014 Annual Financial Report). It explicitly states that the Annual Financial Report for the year ended December 31, 2014, has been made available to the public and filed with the AMF (Autorité des Marchés Financiers). The document itself is very short (2635 characters) and serves primarily to announce the availability of the full report, rather than containing the full report content. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published points towards a Report Publication Announcement (RPA). Although the content relates to the Annual Report (10-K), the document's function here is the announcement of its publication.
2015-04-15 French
Mauna Kea Technologies : Comptes consolidés selon les normes IFRS au 31 décembre 2014
Audit Report / Information Classification · 98% confidence The document contains detailed financial statements in French, including the 'ETAT DE LA SITUATION FINANCIERE' (Balance Sheet), 'ETAT DU RESULTAT GLOBAL' (Statement of Comprehensive Income), 'ETAT DES VARIATIONS DES CAPITAUX PROPRES' (Statement of Changes in Equity), and 'TABLEAU DE FLUX DE TRESORERIE' (Cash Flow Statement). It explicitly states the period covered: 'Comptes consolidés selon les normes IFRS au 31 décembre 2014'. This structure and content are characteristic of a full annual financial report, which corresponds to the 10-K filing category in the US context, or its equivalent comprehensive annual filing. Since the definitions provided map 'Official yearly report covering company activity and full financial performance' to '10-K', this is the most appropriate classification, despite the document being in French. FY 2014
2015-04-15 French
Mauna Kea Technologies : Résultats annuels 2014 et chiffres d'affaires du T1 2015
Earnings Release Classification · 95% confidence The document is a comprehensive financial announcement from Mauna Kea Technologies detailing both the full-year 2014 annual results and the Q1 2015 revenue figures. It includes detailed financial tables (IFRS), management commentary, operational highlights, and clinical/regulatory updates. While it covers annual results, it is structured as a press release/announcement rather than a full 10-K or statutory annual report document. Given the inclusion of substantive financial data and analysis for both the annual and quarterly periods, it fits the definition of an Earnings Release (ER) as it serves as the initial announcement of these financial results. Q1 2015
2015-04-14 French
Mauna Kea Technologies: 2014 Full Year Results and Q1 2015 Sales
Earnings Release Classification · 97% confidence The document explicitly announces the company's "2014 FULL-YEAR RESULTS AND Q1 2015 SALES". It contains detailed financial tables for the full year 2014 (including Sales, Operating Income, Net Profit/Loss) and specific sales figures for Q1 2015. This structure—presenting comprehensive annual financial performance alongside a recent quarterly update—is characteristic of an Earnings Release (ER) or a combined Annual/Quarterly report announcement. Since it provides the detailed results and analysis (not just a brief announcement that results are forthcoming), it is more substantial than a simple RPA. However, it is not the full, audited 10-K document, but rather the initial announcement of the results. The definition for Earnings Release (ER) is: "Initial announcement of quarterly/periodical financial results (key highlights only)". While this document is quite detailed, it serves the primary function of releasing the period's financial performance figures immediately following the Board meeting, which aligns best with ER, or potentially IR (Interim Report) if the annual part is considered the primary focus, but ER covers the immediate release of periodic results best. Given the dual focus on FY 2014 results and Q1 2015 sales, ER is the most appropriate fit for this type of press release announcing period results. Q1 2015
2015-04-14 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is dated April 8, 2015, and its title is "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article L233-8-II of the French Commercial Code and Article 223-16 of the AMF General Regulation. The content provides a table detailing the number of shares and voting rights as of March 31, 2015. This type of mandatory monthly disclosure regarding the total number of shares and voting rights in France is typically classified as a regulatory filing or a specific disclosure related to capital structure/voting rights. Given the options, it most closely aligns with a mandatory regulatory disclosure concerning share capital and voting rights, which is often captured under general regulatory filings (RNS) or, if a more specific category existed for share capital changes, that would be preferred. However, since it is a specific, recurring regulatory disclosure about the capital base, and not a major event like a dividend announcement (DIV) or share issue (SHA), RNS (Regulatory Filings) serves as the best fit for this type of routine regulatory update not covered by other specific codes like DIRS or MRQ (which focus on ownership changes, not the total count). The document length is short (1573 chars), but it is the report itself, not an announcement of a report.
2015-04-08 French
Mauna Kea Technologies: Grenoble University Hospital first hospital in France to set up a multidisciplinary optical biopsy program with the Cellvizio endomicroscopy platform
Regulatory Filings Classification · 95% confidence The document is a press release dated March 31, 2015, announcing that the Grenoble University Hospital has set up a multidisciplinary optical biopsy program using Mauna Kea Technologies' Cellvizio platform. It details the application areas (gastroenterology, pulmonology, urology) and includes quotes from hospital staff and a description of the technology company. This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a general corporate update about a business development or partnership, fits best under the 'Regulatory Filings' (RNS) category as a general announcement, or potentially 'LTR' if it were about a legal matter, but here it is a positive business development announcement. Given the options, RNS serves as the best general regulatory/corporate announcement fallback when specific categories like M&A (TAR) or Capital Change (CAP) do not apply. It is clearly not a report itself, an earnings release, or a management discussion.
2015-03-31 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.